Pictet Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130M Buy
1,220,353
+118,105
+11% +$14.3M 0.12% 186
2026
Q1
$179M Buy
1,102,248
+143,285
+15% +$22M 0.19% 132
2025
Q4
$167M Sell
958,963
-181,864
-16% -$33.2M 0.16% 151
2025
Q3
$164M Sell
1,140,827
-412,801
-27% -$50.6M 0.16% 159
2025
Q2
$156M Sell
1,553,628
-459,701
-23% -$35.1M 0.16% 151
2025
Q1
$154M Buy
2,013,329
+53,611
+3% +$4.1M 0.17% 144
2024
Q4
$135M Buy
1,959,718
+96,377
+5% +$6.94M 0.15% 167
2024
Q3
$136M Buy
1,863,341
+372,206
+25% +$27.5M 0.15% 168
2024
Q2
$99.9M Sell
1,491,135
-38,873
-3% -$1.51M 0.11% 189
2024
Q1
$41.5M Sell
1,530,008
-431,793
-22% -$12.1M 0.05% 346
2023
Q4
$60.8M Sell
1,961,801
-451,637
-19% -$11.7M 0.07% 270
2023
Q3
$60.9M Buy
+2,413,438
New +$55.2M 0.08% 261

Other funds holding INSM

Pictet Asset Management's INSM Position: Q2 2026 in Review

Pictet Asset Management increased its Insmed (INSM) stake by 11% in Q2 2026, buying an estimated $14.3M and bringing the position to 1,220,353 shares worth $130M. The position accounts for 0.12% of the portfolio, ranked #186.

Pictet Asset Management first reported a position in INSM in Q3 2023 and has held it in 12 quarters since. The position peaked at $179M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Pictet Asset Management held 1,220,353 shares of Insmed worth $130M as of Q2 2026.
  • Pictet Asset Management bought 118,105 Insmed shares in Q2 2026, an estimated $14.3M.
  • Insmed made up 0.12% of Pictet Asset Management's portfolio in Q2 2026, its #186 holding.
  • Pictet Asset Management first reported a position in Insmed in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Insmed position peaked at $179M in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.